College of Pharmacy, The Second Clinical Medical College (Shenzhen People's Hospital), The Fifth Affiliated Hospital, Jinan University, Guangzhou 510632, China.
College of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China.
Biosens Bioelectron. 2024 Mar 15;248:115993. doi: 10.1016/j.bios.2023.115993. Epub 2023 Dec 30.
Simultaneous, reliable, and ultra-sensitive analysis of promising miRNA biomarkers of colorectal cancer (CRC) in serum is critical for early diagnosis and prognosis of CRC. In this work, we proposed a novel 3D hierarchic assembly clusters-based SERS strategy with dual enrichment and enhancement designed for the ultrasensitive and quantitative analysis of two upregulated CRC-related miRNAs (miR-21 and miR-31). The biosensor contains the following: (1) SERS probe, Au nanocage@Au nanoparticles (AuNC@Au NPs) labeled with Raman reporters (RaRs). (2) magnetic capture unit, Ag-coated FeO magnetic nanoparticles (AgMNPs) modified with internal standard (IS). (3) signal amplify probes (SA probes) for the formation of hierarchic assembly clusters. Based on this sensing strategy, the intensity ratio I/I with Lg miRNAs presents a wide linear range (10 aM-100 pM) with a limit of detection of 3.46 aM for miR-21, 6.49 aM for miR-31, respectively. Moreover, the biosensor shows good specificity and anti-interference ability, and the reliability and repeatability of the strategy were then verified by practical detection of clinical serum. Finally, the biosensor can distinguish CRC cancer subjects from normal ones and guide the distinct tumor, lymph node, and metastasis (TNM) stages. Overall, benefiting from the face-to-face coupling of hierarchic assembly clusters, rapid magnetic enrichment and IS signal calibration of AgMNPs, the established biosensor achieves ultra-sensitive and simultaneous detection of dual miRNAs and opens potential avenues for prediction and staging of CRC.
同时,可靠和超灵敏的分析有前途的结直肠癌(CRC)血清中的 miRNA 生物标志物对于 CRC 的早期诊断和预后至关重要。在这项工作中,我们提出了一种新颖的基于 3D 分级组装簇的 SERS 策略,具有双富集和增强功能,用于超灵敏和定量分析两种上调的 CRC 相关 miRNA(miR-21 和 miR-31)。该生物传感器包含以下部分:(1)SERS 探针,Au 纳米笼@Au 纳米颗粒(AuNC@Au NPs)标记有拉曼报告物(RaRs)。(2)磁性捕获单元,Ag 包覆的 FeO 磁性纳米颗粒(AgMNPs)修饰有内标(IS)。(3)用于形成分级组装簇的信号放大探针(SA 探针)。基于这种传感策略,强度比 I/I 与 Lg miRNAs 呈现出宽的线性范围(10 aM-100 pM),miR-21 的检测限为 3.46 aM,miR-31 的检测限为 6.49 aM。此外,该生物传感器表现出良好的特异性和抗干扰能力,然后通过临床血清的实际检测验证了该策略的可靠性和可重复性。最后,该生物传感器能够区分 CRC 癌症患者和正常人,并指导不同的肿瘤、淋巴结和转移(TNM)阶段。总的来说,得益于分级组装簇的面对面偶联、AgMNPs 的快速磁性富集和 IS 信号校准,所建立的生物传感器实现了双重 miRNA 的超灵敏和同时检测,并为 CRC 的预测和分期开辟了潜在途径。
Biosens Bioelectron. 2021-10-15
Biomed Eng Online. 2025-6-3
Anticancer Agents Med Chem. 2024